View in EDS

Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

Saved in:
Bibliographic Details
Title: Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.
Authors: Twelves, C.1, Scheithauer, W.2, McKendrick, J.3, Seitz, J.-F.4, Van Hazel, G.5, Wong, A.6, Díaz-Rubio, E.7, Gilberg, F.8, Cassidy, J.9
Source: Annals of Oncology. May2012, Vol. 23 Issue 5, p1190-1197. 8p. 2 Diagrams, 4 Charts, 2 Graphs.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdr366